rethinkPeptides Search
Menu
Study breakdown

BPC-157 Protects Against NSAID Gut Damage and Leaky Gut Syndrome

ReviewModerate evidence
The takeaway

BPC-157 rescues NSAID-induced gastrointestinal damage by stabilizing intestinal permeability, protecting endothelium, and exerting cytoprotective effects across multiple organ systems.

Multi-organ cytoprotection

BPC-157 protects against NSAID damage in stomach, intestines, liver, pancreas, heart, and brain

What the researchers found

BPC-157 rescues NSAID-induced gut damage by stabilizing intestinal permeability and providing cytoprotection across the GI tract and other organs, potentially addressing leaky gut syndrome.

Why it matters

NSAID use is widespread and GI side effects affect millions. A peptide that specifically protects the gut lining from NSAID damage could prevent a major source of medication-related morbidity.

The numbers in context

BPC-157 counteracts NSAIDs, alcohol, bile acids, stress on gut permeability; protective in stomach, intestine, skin, liver, pancreas, heart, brain

How the study worked

Narrative review compiling evidence for BPC-157 cytoprotective and organoprotective effects against NSAID-induced damage, intestinal permeability changes, and endothelial injury.

Who was studied

Not applicable (review of preclinical studies)

What this study cannot tell us

Review without new experimental data; most evidence from animal studies; human clinical trials for NSAID gastroprotection are lacking; mechanisms not fully elucidated.

How to read the evidence

Comprehensive review of preclinical evidence showing consistent cytoprotective effects, but human clinical data specifically for NSAID gastroprotection is absent.

When this study was published

Published in 2020; BPC-157 remains widely studied preclinically but lacks Phase III clinical trials for any indication.

The bigger picture

BPC-157's broad cytoprotective profile — from stomach to brain — suggests it activates fundamental cell survival pathways rather than organ-specific mechanisms, positioning it as a systemic protectant.

Questions still open

  • Can BPC-157 be co-administered with NSAIDs to prevent gut damage in clinical practice?
  • How does BPC-157 compare to proton pump inhibitors for NSAID gastroprotection?
  • What is the molecular mechanism by which BPC-157 stabilizes intestinal tight junctions?

Common questions

Can BPC-157 protect against ibuprofen stomach damage?
Preclinical evidence shows BPC-157 stabilizes gut permeability and protects the gastrointestinal lining from NSAID damage, though human clinical trials have not yet been conducted.
What is leaky gut and can BPC-157 help?
Leaky gut occurs when intestinal permeability increases, allowing harmful substances to pass through. BPC-157 has been shown to stabilize intestinal permeability in preclinical studies, potentially addressing this condition.

Read the original research

BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.

Current pharmaceutical design, 26(25), 2971-2981

Citation

Park, Jong M; Lee, Ho J; Sikiric, Predrag; Hahm, Ki B. (2020). BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.. Current pharmaceutical design, 26(25), 2971-2981. https://doi.org/10.2174/1381612826666200523180301